Uncategorised - European Medical Journal

HLTH Europe 2025 Interview: Henry Stoneley

The theme for HLTH Europe 2025 was intentionally chosen. Growth can be exhilarating; it can feel like momentum…

Postbiotics Show Promise in Slowing Liver Fibrosis

While the primary outcome, a ≥10% reduction in α-SMA, was reached in 29% of ReFerm® recipients versus 14% in the control group, the difference was not statistically significant.

Artificial Sweetener Erythritol Linked to Brain Vascular Cell Dysfunction

Erythritol at common dietary levels impairs brain endothelial cell function, raising new concerns for cerebrovascular health.

Smoking and Obesity Lower TNFi Success in axSpA

A European study of nearly 15,000 patients finds that smoking and high BMI lower the odds of response to TNF inhibitors in axial spondyloarthritis.

WHO Backs Twice-Yearly Lenacapavir Injection for HIV Prevention

WHO has endorsed injectable lenacapavir as a twice-yearly HIV prevention tool, offering new hope for communities facing high infection risks and adherence barriers.

Long-Term Psoriasis Drug Use Shows Low Cancer Risk

This post hoc analysis included data from 25 randomised clinical trials, assessing over five years of IXE exposure in patients with psoriasis.

EHA Presidential Interview: Konstanze Döhner

My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…

New Imaging Index Forecasts Lymphoma Progression

A novel deep learning approach to body composition analysis may offer a cost-effective and clinically relevant method to predict treatment outcomes in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to findings from the LOTIS-2 trial.

How Menopause Alters Systemic Sclerosis Outcomes

Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.

More Infants Treated for Hemangiomas Post-Beta-Blocker Era

The use of beta-blockers has dramatically changed the management of infantile hemangiomas, with a significant increase in active treatment decisions at tertiary referral centers, according to a new retrospective cohort study.